Traws Pharma, Inc. 

12 Penns Trail 

Newtown, PA 18940

 

August 26, 2024

 

VIA EDGAR

 

Securities and Exchange Commission 

Division of Corporation Finance 

Office of Life Sciences 

100 F Street, N.E. 

Washington, D.C. 20549

 

Attention:

Doris Gama and Laura Crotty

 

	Re:	Traws Pharma, Inc.
		Registration Statement on Form S-3
		Filed July 1, 2024
		File No. 333-280642

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Traws Pharma, Inc. (the “Company”) hereby requests acceleration of the effective date of the above referenced registration statement, as amended, so that such registration statement may become effective at 4:30 p.m. (Washington, D.C. time) on August 28, 2024, or as soon as practicable thereafter.

 

TRAWS PHARMA, INC.

 

By:	/s/ MARK GUERIN
Name:	Mark Guerin
Title:	Chief Financial Officer